{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:05Z","timestamp":1753891265754,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The lifetime risk of ovarian cancer is 1 in 75, and it is often diagnosed at an advanced stage due to the lack of effective screening. Epithelial ovarian cancer (EOC) is the most common type of ovarian cancer in older patients, with borderline ovarian tumors (BOTs) accounting for 15% of EOC cases. BOTs are usually of low malignant potential. Since platinum-based chemotherapy has not been shown to improve survival rates, cytoreductive surgery (CRS) is recommended as a treatment option. Additionally, endometriosis affects 10.5% of patients with EOC. It often progresses to clear cell and endometrioid ovarian cancer. This progression is believed to result from repetitive cycles of inflammation, mutations in multiple pathways, and microsatellite instability. While other types of cancers, such as BOTs, can arise in cases of endometriosis, they are less common. This case report describes an unusual case of a 62-year-old female patient who appeared to present with advanced-stage epithelial ovarian cancer (EOC) but was unexpectedly diagnosed with a borderline ovarian tumor (BOT) accompanied by extensive endometriosis. The patient\u2019s history of endometriosis, infertility, and low parity increased her risk of developing a BOT; however, her age at presentation was unusual. The key clinical feature of this case that contributes to the existing literature is the vital role of pathology in guiding chemotherapy decisions, particularly when there is disease progression despite ongoing treatment. This highlights the necessity of a thorough history and physical examination, as several aspects in the patient\u2019s medical history were suggestive of a BOT. The patient initially presented with emesis, abdominal distention, postmenopausal bleeding, and a large, rapidly growing pelvic mass, which raised the initial suspicion of advanced EOC. However, she was unable to undergo surgery due to supraventricular tachycardia and venous thromboembolism (VTE) caused by the mass effect of the tumor. Despite being medically unstable, an exploratory laparotomy with resection of the mass was performed. Pathology revealed a stage 1C3 serous BOT within a large endometrioma. Chemotherapy was not required postoperatively. The patient remained under close observation by gynecologic oncology for surveillance, hematology for managing her VTE, and cardiology for monitoring her supraventricular tachycardia (SVT).<\/jats:p>","DOI":"10.3389\/fmed.2025.1581241","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:26Z","timestamp":1750138106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Serous borderline ovarian tumor and extensive abdominopelvic endometriosis mimicking advanced epithelial ovarian cancer in a postmenopausal patient"],"prefix":"10.3389","volume":"12","author":[{"given":"Katherine","family":"Livatova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Pizzuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"McEachron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13048-021-00865-2","article-title":"Association between atypical endometriosis and ovarian malignancies in the real world","volume":"14","author":"So","year":"2021","journal-title":"J Ovarian Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ygyno.2003.09.005","article-title":"Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer","volume":"92","author":"Webb","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e28864","DOI":"10.7759\/cureus.28864","article-title":"Endometriosis: a review of clinical diagnosis, treatment, and pathogenesis","volume":"14","author":"Chauhan","year":"2022","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/13697137.2021.1948994","article-title":"Endometriosis-associated cancer","volume":"24","author":"Guidozzi","year":"2021","journal-title":"Climacteric"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.2147\/CMAR.S250394","article-title":"The diagnosis, treatment, prognosis and molecular pathology of borderline ovarian tumors: current status and perspectives","volume":"12","author":"Sun","year":"2020","journal-title":"Cancer Manag Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/PGP.0b013e31821f4b85","article-title":"Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects","volume":"30","author":"Wei","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"100053","DOI":"10.1016\/j.eurox.2019.100053","article-title":"Endometriosis and ovarian cancer: their association and relationship","volume":"3","author":"Bas-Esteve","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1080\/01443615.2018.1441815","article-title":"Concomitant endometriosis in malignant and borderline ovarian tumours","volume":"38","author":"Oral","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13048-021-00940-8","article-title":"Predictive factors of endometriosis progression into ovarian cancer","volume":"15","author":"Varga","year":"2022","journal-title":"J Ovarian Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/amhs.amhs_48_23","article-title":"Ovarian endometriosis with borderline serous tumor: a rare occurrence","volume":"11","author":"Rana","year":"2023","journal-title":"Arch Med Health Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ygyno.2017.01.002","article-title":"Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: a nationwide case-control study","volume":"144","author":"Rasmussen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/humrep\/deh890","article-title":"Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas","volume":"20","author":"Kitawaki","year":"2005","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.29252\/ijrm.14.11.713","article-title":"Correlation of CA-125 serum level and clinico-pathological characteristic of patients with endometriosis","volume":"14","author":"Karimi-Zarchi","year":"2016","journal-title":"Int J Reprod Biomed"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"108873","DOI":"10.1016\/j.ijscr.2023.108873","article-title":"Infected, giant borderline ovarian tumor: a case report","volume":"111","author":"Gharbia","year":"2023","journal-title":"Int J Surg Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e23968","DOI":"10.7759\/cureus.23968","article-title":"Giant borderline mucinous cystadenoma: a distressing scenario","volume":"14","author":"Deo","year":"2022","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"106099","DOI":"10.1016\/j.ijscr.2021.106099","article-title":"Borderline serous tumor of the ovary discovered during pregnancy: a case report","volume":"84","author":"Cheikh","year":"2021","journal-title":"Int J Surg Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13256-020-02597-1","article-title":"Ovarian borderline tumor presenting as ovarian torsion in a 17-year-old patient: a case report","volume":"15","author":"Vicente","year":"2021","journal-title":"J Med Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"20210116","DOI":"10.1259\/bjr.20210116","article-title":"Serous borderline ovarian tumours: an extensive review on MR imaging features","volume":"94","author":"Sahin","year":"2021","journal-title":"Br J Radiol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1581241\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:27Z","timestamp":1750138107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1581241\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":20,"alternative-id":["10.3389\/fmed.2025.1581241"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1581241","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1581241"}}